NanoRepro AG
XETRA: NN6.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Lisa Jungst
- Employees
- 22
- Headquarters
- Marburg, Germany
- IPO year
- 2009
- Market cap
- €18.9M
- Website
- https://www.nanorepro.com
Loading NN6…
Loading profile data…Frequently asked questions about NN6
What does NanoRepro AG (NN6.DE) do?
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, inc...
Where does NN6.DE trade?
NanoRepro AG (NN6.DE) trades on the Deutsche Börse.
What sector is NN6.DE in?
NanoRepro AG (NN6.DE) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of NanoRepro AG?
Lisa Jungst is the chief executive officer of NanoRepro AG (NN6.DE).
Where is NanoRepro AG headquartered?
NanoRepro AG is headquartered in Germany.
Does NN6.DE pay a dividend?
NanoRepro AG (NN6.DE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NN6.DE go public?
NanoRepro AG (NN6.DE) completed its initial public offering in 2009.